570 related articles for article (PubMed ID: 19358195)
1. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with nonparticipation in one-year quality-of-life assessment in patients with head and neck squamous cell carcinoma.
Gourin CG; Kaboli KC; Boyce BJ; Burkhead LM
Laryngoscope; 2010 Jul; 120(7):1435-43. PubMed ID: 20564472
[TBL] [Abstract][Full Text] [Related]
4. Influences and predictors of long-term quality of life in head and neck cancer survivors.
El-Deiry MW; Futran ND; McDowell JA; Weymuller EA; Yueh B
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):380-4. PubMed ID: 19380361
[TBL] [Abstract][Full Text] [Related]
5. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
7. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
[TBL] [Abstract][Full Text] [Related]
8. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and recurrence concern in survivors of head and neck cancer.
Campbell BH; Marbella A; Layde PM
Laryngoscope; 2000 Jun; 110(6):895-906. PubMed ID: 10852502
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.
Li X; Di B; Shang Y; Zhou Y; Cheng J; He Z
Eur J Surg Oncol; 2009 Dec; 35(12):1348-53. PubMed ID: 19616915
[TBL] [Abstract][Full Text] [Related]
11. Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck squamous cell carcinoma patients.
Aarstad AK; Aarstad HJ; Bru E; Olofsson J
Clin Otolaryngol; 2005 Dec; 30(6):530-8. PubMed ID: 16402979
[TBL] [Abstract][Full Text] [Related]
12. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
13. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes.
Andruchow JL; Veness MJ; Morgan GJ; Gao K; Clifford A; Shannon KF; Poulsen M; Kenny L; Palme CE; Gullane P; Morris C; Mendenhall WM; Patel KN; Shah JP; O'Brien CJ
Cancer; 2006 Mar; 106(5):1078-83. PubMed ID: 16444748
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma.
Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O
Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472
[TBL] [Abstract][Full Text] [Related]
15. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
17. Changes in quality of life over 1 year in patients with head and neck cancer.
Ronis DL; Duffy SA; Fowler KE; Khan MJ; Terrell JE
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):241-8. PubMed ID: 18347247
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
20. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]